Florida · Nonprofit
FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC
FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC (Florida) receives grants from 3 organizations whose IRS filings report $15,479 to it, the largest being PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA ($8,000). 1 of them have funded it in more than one year.
- Revenue FY2024
- $3.8M
- Funders on record
- 3
- Grants received
- $15k
- Net assets
- $5.9M
What Florida Society of Clinical Oncology Inc does
Mission
The florida society of clinical oncology is a statewide non-profit organization committed to facilitating and promoting multidisciplinary efforts to improve patient care in florida by:- fostering access to quality cancer care to the citizens of florida.- assisting the cancer practitioners in providing the most cost effective quality care for their patients.- acting as an advocate for florida cancer patients and their families.- coordinating the dissemination of information and providing an opportunity for oncologists, physicians, and other health care professionals to network and exchange information.
As stated on its FY2024 Form 990.
Program
Education and professional developmentflasco provides year-round educational programming to advance oncology practice and improve patient careacross florida. In 2024, flasco hosted over ten in-person meetings for clinicians, along with a statewidewebinar and an educational podcast to expand access to learning. Major events included the spring congressand business of oncology summit, the fall session and oncology congress, and multiple offerings within theclinical oncology series. These activities brought together physicians, nurses, pharmacists, and otherprofessionals for updates on clinical advances, practice management, and emerging therapies.specialty activities focused on advanced practice providers, nursing education, financial toxicity, and rapidintegrations in clinical practice. Flasco also provided education on legislative and policy issues that affectoncology delivery and patient access to care, helping clinicians understand and navigate changes that impacttheir ability to serve patients.flasco continued to invest in early-career development through the flasco young investigator award and fellowship travel grants that support participation in national oncology meetings.…
$1,888,748 spentof which $28,061 as grants$484,413 earned by the program100% of program spending
The program described on its FY2024 Form 990. Program spending in total: $1,888,748.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2023 to 2024, from $4.5M to $5.9M (+29%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
85% of FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC’s revenue is contributions — more donation-reliant than the typical peer (51% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 0 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Julie Newberry
Executive director
As listed on its FY2024 Form 990.
Who funds it, year by year
2017 → 2023: the base held at 1 funder, grant income fell $7k → $92.
1 of 3 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 1% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC leans on a few funders — its largest provides 52% of grant income and the top three 100%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC.
Largest funder’s share by year: 2017 100% · 2020 100% · 2021 100% · 2022 99% · 2023 100% — broadly stable.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC draws 52% of its grant income from funders outside Florida, across 2 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $229 arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC runs a healthier operating margin than three-quarters of the 8,121 health nonprofits its size.
this organization peer median middle 50% of peers· 8,121 health nonprofits $1M–$10M, FY2024
Organizations like FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Florida
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
74% of spending goes to programs.
Governance
Public support
99%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC?
- FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC (Florida) receives grants from 3 organizations whose IRS filings report $15,479 to it, the largest being PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA ($8,000). 1 of them have funded it in more than one year.
- How many funders does FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC have?
- IRS filings report 3 organizations giving $15,479 in grants to FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC, 1 of which have funded it in more than one year.
- Who is the largest funder of FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC?
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA is the largest funder on record, with $8,000 in grants. The full list of funders is on this page.
- How can an organization like FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Florida. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 3 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing